🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase Ib trial studies the side effects of pembrolizumab and trametini...
Status
Completed
Location
University of California Davis Comprehensive Cancer Center
Start Date
2018-06-26
Trial ID
NCT03299088
Treatments Being Tested
This phase II trial studies how well dabrafenib, trametinib, and spartalizu...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2020-01-29
Trial ID
NCT04310397
Treatments Being Tested
This study is looking at outcomes in people with advanced cancers who have ...
Status
Terminated
Location
Peter MacCallum Cancer Centre
Start Date
2021-09-23
Trial ID
NCT04801966
Ameloblastoma is the most common benign odontogenic tumor, characterized by...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-03-01
Trial ID
NCT06819605
Treatments Being Tested
This research study is studying a combination of drugs as a possible treatm...
Status
Unknown
Location
Massachusetts General Hosital Cancer Center
Start Date
2018-10-15
Trial ID
NCT03668431
Treatments Being Tested
This is a single arm phase II trial focused on how dabrafenib and trametini...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2014-10-22
Trial ID
NCT02231775
Treatments Being Tested
This phase 2 trial will investigate the efficacy and safety of trametinib a...
Status
Completed
Location
Universitair Ziekenhuis Brussel
Start Date
2019-01-28
Trial ID
NCT04059224
Treatments Being Tested
This study is a Phase 1 dose-escalation open-label study to determine the r...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-05-04
Trial ID
NCT01138085
Treatments Being Tested
This pilot clinical trial studies the feasibility of choosing treatment bas...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2015-09-11
Trial ID
NCT02551718
This study is being done to find out if the combination of dabrafenib, tram...
Status
Withdrawn
Location
University of Texas Southwestern Medical Center
Start Date
2016-10
Trial ID
NCT02915666
Treatments Being Tested